Randomized trial of immuno-enhancing enteral nutrition in esophageal cancer patients undergoing chemoradiation

Randomized trial of immuno-enhancing enteral nutrition in esophageal cancer patients undergoing chemoradiation - Immuno-enhancing enteral nutrition in esophageal cancer patients undergoing chemoradiation

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004732

Enrollment

Registered

2010-12-30

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal carcinoma

Interventions

immuno-enhancing enteral nutrition (Neomune) enteral nutrition (Blendera)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -squamous cell esophageal carcinoma -sign consent

Exclusion criteria

Exclusion criteria: -ECOG2 or over -with organ metastasis -with other active cancer

Design outcomes

Primary

Measure	Time frame
reduce side effects of chemoradiation	—

Secondary

Measure	Time frame
cytokine levels	—

Countries

Asia(except Japan)

Contacts

Public ContactSomkiat Sunpaweravong, MD

Prince of Songkla University Hospital, Songkla, 90110 Thailand Department of Surgery

susomkia@medicine.psu.ac.th6674-429384

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026